Results 61 to 70 of about 14,903 (246)

The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma

open access: yesFrontiers in Endocrinology
ObjectiveTo explore the clinical benefits of 125I seed implantation for iodine-refractory differentiated thyroid cancer (RAIR-DTC).MethodsA retrospective analysis was conducted on 36 patients with RAIR-DTC who underwent radioactive 125I seed implantation
Qin Wan   +7 more
doaj   +1 more source

Current concepts of 131I therapy in oncology: Indications, methods and follow up [PDF]

open access: yesArchive of Oncology, 2006
Radioiodine in various forms (as sodium iodide and as the iodinated compounds MIBG, LIPIODOL, et al.) has been used as a therapeutic agent in oncology. Differentiated thyroid carcinoma (DTC) has been successfully treated by 131I therapy.
Mihailović Jasna
doaj   +1 more source

Review of Past Nuclear Accidents: Source Terms and Recorded Gamma-Ray Spectra [PDF]

open access: yes, 1997
Airborne gamma ray spectrometry using high volume scintillation detectors, optionally in conjunction with Ge detectors, has potential for making rapid environmental measurements in response to nuclear accidents.
Allyson, J.D.   +4 more
core  

Engineered Elastin‐Like Polypeptides: Intelligent Self‐Assembling Platforms for Biomedical Application

open access: yesSmall Structures, Volume 7, Issue 3, March 2026.
Armed with unique structural and functional properties, elastin‐like polypeptides attract their attentions as programmable materials in biomedical applications, including fusion tags for protein and nucleic acid purification; nanocarriers for protein, chemotherapeutics, and imaging agent delivery; hydrogels for tissue regeneration, 3D model ...
Yang Yuan   +9 more
wiley   +1 more source

Cryosurgery combined with Iodine-125 seed implantation in the treatment of unresectable lung cancer

open access: yesChinese Journal of Lung Cancer, 2008
Background and objective As many lung cancer patients lose surgical possibility, it is important to explore new treatments to improve prognosis. The study is to observe adverse reactions and therapeutic effects of cryosurgery combined iodine-125 seeds ...
Hongta ZHOU   +7 more
doaj  

A Modified Method for Increasing Radiochemical Purity of I-125 for Radiopharmaceuticals

open access: yesAtom Indonesia, 2023
Iodine-125 (125I) is one of the radioisotopes widely used in radiopharmaceuticals for diagnosis and therapy of various cancers. Recent reports indicate that there has been shortages in the world supply of this radioiodine isotope.
M Maiyesni   +6 more
doaj   +1 more source

Sorption efficiency of radioactive iodine compounds by nuclear-grade activated carbon - a review and processing of literature data

open access: yesFrontiers in Nuclear Engineering
The sorption properties of I2 and CH3I on activated carbon were reviewed. The dependence of the sorption capacity on activated carbon of iodine and methyl iodide in air or effluent gas on the sampling operating conditions (temperature, relative humidity,
Bandombele Marcel Mokili   +2 more
doaj   +1 more source

Early Diagnosis of Alzheimer's disease by NIRF Spectroscopy and Nuclear Medicine [PDF]

open access: yes, 2011
There is an urgent need for the early detection of diseases such as Alzheimer’s (AD) and Cancers in order to enable their successful treatment. Cancer is the second major cause of death after Heart Disease, and AD is the third major cause of death
I. C. Baianu
core   +1 more source

Myopathy following postoperative ablative radioiodine for follicular carcinoma of the thyroid

open access: yesInternational Medical Case Reports Journal, 2009
Hermione C Price, Vijay JayagopalCentre for Diabetes and Endocrinology, York Hospital, York, UKAbstract: We highlight a case of disabling myopathy following radioablative iodine treatment for follicular carcinoma of the thyroid.
Hermione C Price, Vijay Jayagopal
doaj  

Integrating Nuclear Medicine Services Into Health Care Systems in Low‐ and Middle‐Income Countries: A Review of Challenges and Innovations

open access: yesiRADIOLOGY, Volume 4, Issue 1, Page 3-12, February 2026.
Nuclear medicine is capable of solving noncommunicable diseases in LMICs but poses its own challenges. Research and investments are still needed. For nuclear medicine to answer the dynamics of noncommunicable diseases in the LMICs, it would have to overcome the high costs and regulations involved in this practice.
Biruk Demisse Ayalew   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy